InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,668.80
(
0.16%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
-1.63%
)
Bitcoin
60,468.78
(
-4.09%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Jesspro

Send PM Follow Ignore
Followers 41
Posts 6067
Boards Moderated 1
Alias Born 06/29/2011

Jesspro

Re: None

Wednesday, 12/07/2016 12:20:15 AM

Wednesday, December 07, 2016 12:20:15 AM

Post# of 80490
This article seems to suggest that Novartes Zykadia clinical data is better than Ariad's Brigatinib. Am I just reading it wrong? Is Briga just second best now?


http://www.genengnews.com/gen-news-highlights/novartis-and-ariad-separately-report-positive-alk-inhibitor-results/81253504




Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up